美国 · SEC FORM 4
Vericel Corp
VCEL · Nasdaq · CIK 0000887359 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
39 同一窗口内观察到的 Form 4 交易行
20 sales · 19 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 5 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot.—
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 5,202,417
- 上期报告
- 5,483,102
- 日均成交量
- 539,786
- 回补天数
- 9.6
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
本地 Form 4 历史中没有合资格的代码 P 股票买入。
Form 4 申报证据
110 transaction lines in the latest 365-day window; 618 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-12 | MCLAUGHLIN KEVIN F | 卖出 (S) | Common Stock | 7,000 | USD 44.53 | USD 311,710 | SEC 申报 ↗ |
| 2026-08-12 | MCLAUGHLIN KEVIN F | 期权行权／转换 (M) | Common Stock | 7,000 | USD 13.05 | USD 91,350 | SEC 申报 ↗ |
| 2026-08-03 | Halpin Michael | 卖出 (S) | Common Stock | 10,000 | USD 46.84 | USD 468,400 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-12 | MCLAUGHLIN KEVIN F | 卖出 (S) | Common Stock | 7,000 | USD 44.53 | USD 311,710 | SEC 申报 ↗ |
| 2026-08-12 | MCLAUGHLIN KEVIN F | 期权行权／转换 (M) | Common Stock | 7,000 | USD 13.05 | USD 91,350 | SEC 申报 ↗ |
| 2026-08-03 | Halpin Michael | 卖出 (S) | Common Stock | 10,000 | USD 46.84 | USD 468,400 | SEC 申报 ↗ |
| 2026-08-03 | Halpin Michael | 期权行权／转换 (M) | Common Stock | 10,000 | USD 16.66 | USD 166,600 | SEC 申报 ↗ |
| 2026-07-30 | SIEGAL JONATHAN | 卖出 (S) | Common Stock | 4,500 | USD 48.90 | USD 220,050 | SEC 申报 ↗ |
| 2026-07-30 | SIEGAL JONATHAN | 期权行权／转换 (M) | Common Stock | 4,500 | USD 31.51 | USD 141,810 | SEC 申报 ↗ |
| 2026-06-26 | SIEGAL JONATHAN | 卖出 (S) | Common Stock | 2,732 | USD 44.90 | USD 122,667 | SEC 申报 ↗ |
| 2026-06-26 | SIEGAL JONATHAN | 期权行权／转换 (M) | Common Stock | 2,500 | USD 29.82 | USD 74,550 | SEC 申报 ↗ |
| 2026-06-26 | Mara Joseph Anthony Jr | 卖出 (S) | Common Stock | 5,000 | USD 44.75 | USD 223,750 | SEC 申报 ↗ |
| 2026-06-26 | Hopper Jonathan Mark | 卖出 (S) | Common Stock | 5,000 | USD 45.00 | USD 225,000 | SEC 申报 ↗ |
| 2026-06-26 | Hopper Jonathan Mark | 期权行权／转换 (M) | Common Stock | 5,000 | USD 29.82 | USD 149,100 | SEC 申报 ↗ |
| 2026-06-26 | Flynn Sean C. | 卖出 (S) | Common Stock | 15,000 | USD 45.64 | USD 684,600 | SEC 申报 ↗ |
| 2026-06-26 | Flynn Sean C. | 期权行权／转换 (M) | Common Stock | 15,000 | USD 16.25 | USD 243,750 | SEC 申报 ↗ |
| 2026-06-18 | Halpin Michael | 卖出 (S) | Common Stock | 10,000 | USD 40.24 | USD 402,400 | SEC 申报 ↗ |
| 2026-06-18 | Halpin Michael | 期权行权／转换 (M) | Common Stock | 10,000 | USD 16.66 | USD 166,600 | SEC 申报 ↗ |
| 2026-06-18 | Flynn Sean C. | 卖出 (S) | Common Stock | 15,000 | USD 40.21 | USD 603,150 | SEC 申报 ↗ |
| 2026-06-18 | Flynn Sean C. | 期权行权／转换 (M) | Common Stock | 15,000 | USD 16.25 | USD 243,750 | SEC 申报 ↗ |
| 2026-06-02 | Hopper Jonathan Mark | 卖出 (S) | Common Stock | 4,375 | USD 35.00 | USD 153,125 | SEC 申报 ↗ |
| 2026-06-02 | Hopper Jonathan Mark | 期权行权／转换 (M) | Common Stock | 4,375 | USD 16.66 | USD 72,888 | SEC 申报 ↗ |
| 2026-05-13 | MCLAUGHLIN KEVIN F | 卖出 (S) | Common Stock | 7,000 | USD 32.83 | USD 229,775 | SEC 申报 ↗ |
| 2026-05-13 | MCLAUGHLIN KEVIN F | 期权行权／转换 (M) | Common Stock | 7,000 | USD 7.84 | USD 54,880 | SEC 申报 ↗ |
| 2026-05-11 | Wotton Paul K | 卖出 (S) | Common Stock | 10,000 | USD 32.74 | USD 327,425 | SEC 申报 ↗ |
| 2026-05-07 | SIEGAL JONATHAN | 卖出 (S) | Common Stock | 1,422 | USD 40.50 | USD 57,591 | SEC 申报 ↗ |
| 2026-05-07 | Mara Joseph Anthony Jr | 卖出 (S) | Common Stock | 5,000 | USD 40.50 | USD 202,500 | SEC 申报 ↗ |
| 2026-05-06 | SIEGAL JONATHAN | 卖出 (S) | Common Stock | 3,433 | USD 38.00 | USD 130,454 | SEC 申报 ↗ |
| 2026-04-29 | ZERBE ROBERT L MD | 期权行权／转换 (M) | Common Stock | 3,200 | USD — | USD — | SEC 申报 ↗ |
| 2026-04-29 | Wotton Paul K | 期权行权／转换 (M) | Common Stock | 3,200 | USD — | USD — | SEC 申报 ↗ |
| 2026-04-29 | WRIGHT LISA | 期权行权／转换 (M) | Common Stock | 3,200 | USD — | USD — | SEC 申报 ↗ |
| 2026-04-29 | Rubino Alan L | 期权行权／转换 (M) | Common Stock | 3,200 | USD — | USD — | SEC 申报 ↗ |
| 2026-04-29 | MCLAUGHLIN KEVIN F | 期权行权／转换 (M) | Common Stock | 3,200 | USD — | USD — | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | VCEL |
| CIK | 0000887359 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2836 Biological Products, (No Diagnostic Substances) |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 618 transaction lines from 2020-02-06 to 2026-08-12 0 P purchase lines · 169 S sale lines · 449 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.